Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gestational Weeks 24-42”

2 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 2 of 2 results

Not applicableStudy completedNCT06314178
What this trial is testing

Assessing Demographic Biases in Deep Learning Model for Fetal Growth Estimation in Clinical Practice. Patients Eligible for Inclusion Are Women with a Gestational Age Between 24-42 Weeks Undergoing a Third-trimester Growth Scan. the Image Data from the Scan Are Used to Calculate Fetal Weight.

Who this might be right for
Pregnancy Complications
Copenhagen Academy for Medical Education and Simulation 185
Not applicableStudy completedNCT04471285
What this trial is testing

Symphysiolysis: Acupuncture Therapeutic Benefits: a Randomized Placebo Controlled Study.

Who this might be right for
Single Embryo PregnancyGestational Weeks 24-42Pain/Sensitivity >5 on Numeric Rating Scale (NRS)
Shaare Zedek Medical Center 80